ReviewHeart (British Cardiac Society)2024
Ebstein's anomaly in children and adults: multidisciplinary insights into imaging and therapy.
Review in Heart (British Cardiac Society), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 23 citations in OpenAlex.
- Simultaneous Heart-Kidney Transplantation for Ebstein's Anomaly: A Viable Treatment Option in Latin America.Clinical case reports · 2026Article
- Prenatal sonographic spectrum and first-trimester diagnostic features of Ebstein anomaly: A descriptive case series.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026Article
- Advanced Echocardiographic Characterization of Neonatal Ebstein's Anomaly Using Myocardial Deformation Imaging: A Single-Center Study.Life (Basel, Switzerland) · 2026Article
- Recurrent atrial fibrillation and stroke in a young adult with congenital heart defects: A case report.Medicine · 2026Article
- Risk factors for morbidity and mortality in Ebstein's anomaly: a registry-based study of 398 patients.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Timely surgical intervention and risk stratification in patients with Ebstein anomaly: a 20-year retrospective cohort study.International journal of surgery (London, England) · 2026Article
- Anatomical severity of Ebstein's anomaly: a quantitative analysis based on cardiovascular MRI.Open heart · 2026Article
- Primary Tricuspid Regurgitation in ACHD: Diagnosis and Treatment.Methodist DeBakey cardiovascular journal · 2026Review
- Echocardiographic characteristics of 14 cases with uncommon manifestation of Ebstein anomaly in the fetus: a case series report.Archives of gynecology and obstetrics · 2025Article
- A multifaceted clinical portrait of Ebstein's anomaly: a case series.European heart journal. Case reports · 2025Article
- Fetal Conduction Disease and Arrhythmia in Ebstein's Anomaly and Tricuspid Valve Dysplasia Assessed by Fetal Magnetocardiography.Journal of the American Heart Association · 2025Observational
- Cone reconstruction after carpentier repair in ebstein anomaly: yes we can!Journal of cardiothoracic surgery · 2025Article
- The Utility of Multimodality Imaging in a Patient with Ebstein Anomaly.CASE (Philadelphia, Pa.) · 2024Article
- Lithium-induced Ebstein's Anomaly.Heart views : the official journal of the Gulf Heart AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although survival has significantly improved in the last four decades, the diagnosis of Ebstein's anomaly is still associated with a 20-fold increased risk of mortality, which generally drops after neonatal period and increases subtly thereafter. With increasing age of presentation, appropriate timing of intervention is challenged by a wide spectrum of disease and paucity of data on patient-tailored interventional strategies. The present review sought to shed light on the wide grey zone of post-neonatal Ebstein's manifestations, highlighting current gaps and achievements in knowledge for adequate risk assessment and appropriate therapeutic strategy.A 'wait-and-see' approach has been adopted in many circumstances, though its efficacy is now questioned by the awareness that Ebstein's anomaly is not a benign disease, even when asymptomatic. Moreover, older age at intervention showed a negative impact on post-surgical outcome.In order to tackle the extreme heterogeneity of Ebstein's anomaly, this review displays the multimodality imaging assessment necessary for a proper anatomical classification and the multidisciplinary approach needed for a comprehensive risk stratification and monitoring strategy. Currently available predictors of clinical outcome are summarised for both operated and unoperated patients, with the aim of supporting the decisional process on the choice of appropriate therapy and optimal timing for intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.